Xiaolin Xu is a PhD candidate in Ho lab. She received her BS from the University of Kentucky in May 2020. Her current research focuses on developing long-acting anticancer drug combination nanoparticles for breast cancer treatment.
Xiaolin Xu is a PhD candidate in Ho lab. She received her BS from the University of Kentucky in May 2020. Her current research focuses on developing long-acting anticancer drug combination nanoparticles for breast cancer treatment.